LIG1 loss exposes a therapeutic vulnerability in triple-negative breast cancer

Loss of 1 transcript of the DNA ligase I (LIG1) cistron successful triple-negative bosom cancers (TNBC) with TP53 mutations confers absorption to chemotherapy, but researchers astatine Baylor College of Medicine and collaborating institutions person identified a vulnerability successful these cells and utilized it to their advantage. The squad identified underlying molecular mechanisms of platinum absorption that they neutralized with combinations of disposable drugs to trim tumor maturation successful carnal models. This enactment besides highlights LIG1 presumption arsenic a diligent stratification origin for ongoing and aboriginal objective trials. The survey appeared successful Molecular Cancer Therapeutics.